Effects of Recombinant Agouti-Signaling Protein on Melanocortin Action
Open accessThe DOI matches its Crossref record.
Abstract
Mouse agouti protein is a paracrine signaling molecule that has previously been demonstrated to be an antagonist of melanocortin action at several cloned rodent and human melanocortin receptors. In this study we report the effects of agouti-signaling protein (ASIP), the human homolog of mouse agouti, on the action of alpha-MSH or ACTH at the five known human melanocortin receptor subtypes (hMCR 1-5). When stably expressed in L cells (hMC1R, hMC3R, hMC4R, hMC5R) or in the adrenocortical cell line OS3 (hMC1R, hMC2R, hMC4R), purified recombinant ASIP inhibits the generation of cAMP stimulated by alpha-MSH (hMC1R, hMC3R, hMC4R, hMC5R) or by ACTH (hMC2R). However, dose-response and Schild analysis indicated that the degree of ASIP inhibition varied significantly among the receptor subtypes; ASIP is a potent inhibitor of the hMC1R, hMC2R, and hMC4R, but has relatively weak effects at the hMC3R and hMC5R. These analyses also indicated that the apparent mechanism of ASIP antagonism varied among receptor subtypes, with characteristics consistent with competitive antagonism observed only at the hMC1R, and more complex behavior observed at the other receptors. ASIP inhibition at these latter receptors, nonetheless, can be classified as surmountable (hMC3R, hMC4R and hMC5R) or nonsurmountable (hMC2R). Recombinant ASIP also inhibited binding of radiolabeled melanocortins, [125I-Nle4, D-Phe7] alpha-MSH and [125I-Phe2, Nle4]ACTH 1-24, to the hMCR 1-5 receptors, with a relative efficacy that paralleled the ability of ASIP to inhibit cAMP accumulation at the hMC1R, hMC2R, hMC3R, and hMC4R. These results provide new insight into the biochemical mechanism of ASIP action and suggest that ASIP may play an important role in modulating melanocortin signaling in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Self-citationThe Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
“and MC4R (which binds AgRP) (349) showed that the N”
BackgroundMetherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437
“This can only be achieved in a limited number of cell types, notably Y6 and OS3 cells, which are of adrenocortical origi”
BackgroundMelanocortin‐1 receptor structure and functional regulation
García‐Borrón, J. C., Sánchez‐Laorden, B. L., & Jiménez‐Cervantes, C. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00278.x · Cited by 385
Hagan, M. M., Rushing, P. A., Pritchard, L. M., Schwartz, M. W., Strack, A. M., Van der Ploeg, L. H. T., Woods, S. C., & Seeley, R. J. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.1.r47 · Cited by 320
The MC4 receptor and control of appetite
Adan, R. A. H., Tiesjema, B., Hillebrand, J. J. G., la Fleur, S. E., Kas, M. J. H., & de Krom, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706929 · Cited by 259
Molecular genetics of human obesity: A comprehensive review
Singh, R. K., Kumar, P., & Mahalingam, K. (2017) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2016.11.007 · Cited by 253
Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo
Ollmann, M. M., Lamoreux, M. L., Wilson, B. D., & Barsh, G. S. (1998) · Genes & Development · doi:10.1101/gad.12.3.316 · Cited by 226
Characterization of Agouti-Related Protein Binding to Melanocortin Receptors
Yang, Y.-K. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.148 · Cited by 189
Self-citationMinireview: the melanocortin 2 receptor accessory proteins
Webb, T. R., & Clark, A. J. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0283 · Cited by 125
Noon, L., Franklin, J., King, P., Goulding, N., Hunyady, L., & Clark, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740017 · Cited by 88
“Two studies have now reported results with this system using cAMP generation studies and radioligand binding techniques (Yang et al. 1997, Elias et al. 1999) and this model has contributed to studies of MC2R desensitization (Baig et al. 2001).”
BackgroundResultThe melanocortin receptors and their accessory proteins
Ramachandrappa, S., Gorrigan, R. J., Clark, A. J. L., & Chan, L. F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00009 · Cited by 87
Inherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Chung, T. T., Webb, T. R., Chan, L. F., Cooray, S. N., Metherell, L. A., King, P. J., Chapple, J. P., & Clark, A. J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1744 · Cited by 82
Cooray, S. N., Almiro Do Vale, I., Leung, K.-Y., Webb, T. R., Chapple, J. P., Egertová, M., Cheetham, M. E., Elphick, M. R., & Clark, A. J. L. (2008) · Endocrinology · doi:10.1210/en.2007-1463 · Cited by 73
The underwhite (uw) locus acts autonomously and reduces the production of melanin
Lehman, A. L., Silvers, W. K., Puri, N., Wakamatsu, K., Ito, S., & Brilliant, M. H. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00107.x · Cited by 42
Pillot, B., Duraffourd, C., Bégeot, M., Joly, A., Luquet, S., Houberdon, I., Naville, D., Vigier, M., Gautier-Stein, A., Magnan, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019107 · Cited by 29
Development of potent selective competitive-antagonists of the melanocortin type 2 receptor
Bouw, E., Huisman, M., Neggers, S. J. C. M. M., Themmen, A. P. N., van der Lely, A. J., & Delhanty, P. J. D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.003 · Cited by 22
Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies
Sanders, K., Mol, J. A., Kooistra, H. S., & Galac, S. (2018) · Veterinary Research Communications · doi:10.1007/s11259-018-9737-x · Cited by 13
“Multiple attempts to create or isolate MC2R antagonists have been made previously (Seelig and Sayers 1973; Yang et al. 1997; Dores 2013), mostly with varying effects.”
Background
Metadata
- Authors
- Yang, Y.-K.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-03-01
- Volume
- 11
- Issue
- 3
- Pages
- 274-280
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W1988992600
- Cited by
- 140
- References
- 0
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.